At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 35 enrolled
Drug / intervention
Marijuana blunt +1 moredrug
Likely dose
Marijuana blunt 800 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison Between Marijuana Smoked in Cigarette Paper (Joints) Versus Cigar Paper (Blunts)
In Brief
A Phase 2 clinical trial evaluating Marijuana blunt and marijuana cigarette for Marijuana Dependence. Completed, enrolled 35 participants across 1 site.
Detailed Summary
The purpose of this study is to investigate whether or not marijuana blunts will produce comparable plasma THC levels as marijuana joints and if blunts will produce larger cardiovascular and subjective effects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMarijuana Dependence
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)
Timeline
Phase 2CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartDec 2004
First PostedSep 2006
Primary CompletionAug 2008
TodayJul 2026
First PostedSep 8, 2006
Enrollment StartDec 1, 2004
Primary CompletionAug 1, 2008
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 19.8 years ago
Interventions
Marijuana bluntdrug
Blunts were fabricated by cutting the bottom third off a Dutch Master® cigar, removing all of the cigar tobacco, and replacing it with all of the marijuana contained in a NIDA marijuana cigarette (ca. 800 mg).
marijuana cigarettedrug
Marijuana cigarettes were provided by the National Institute on Drug Abuse.